多重用药与慢性肾脏病发病率的关联：一项回顾性队列研究：致编辑的一封信 - Suppr

Suppr

超能文献

Association of polypharmacy with incidence of CKD: a retrospective cohort study: a letter to the Editor.

作者信息

Danjuma M I, Alkaabi L, Sayed R, Naseralallah L

机构信息

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Department of Internal Medicine, Weill Cornell College of Medicine, New York and Doha, Qatar.

出版信息

Clin Exp Nephrol. 2024 May;28(5):470-471. doi: 10.1007/s10157-023-02443-w. Epub 2023 Dec 19.

DOI:10.1007/s10157-023-02443-w

PMID:38112981

Abstract

摘要

相似文献

Association of polypharmacy with incidence of CKD: a retrospective cohort study: a letter to the Editor.

Clin Exp Nephrol. 2024 May;28(5):470-471. doi: 10.1007/s10157-023-02443-w. Epub 2023 Dec 19.

Association of polypharmacy with incidence of CKD: a retrospective cohort study.

Clin Exp Nephrol. 2023 Mar;27(3):272-278. doi: 10.1007/s10157-022-02306-w. Epub 2022 Dec 27.

Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.

J Manag Care Spec Pharm. 2021 Jan;27(1):51-63. doi: 10.18553/jmcp.2021.27.1.051.

Association between polypharmacy and chronic kidney disease among community-dwelling older people: a longitudinal study in southern China.

BMC Nephrol. 2024 May 17;25(1):169. doi: 10.1186/s12882-024-03606-x.

Effect modification of polypharmacy on incident frailty by chronic kidney disease in older adults.

BMC Geriatr. 2024 Apr 12;24(1):335. doi: 10.1186/s12877-024-04887-5.

Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study.

J Bone Miner Metab. 2022 Jan;40(1):157-166. doi: 10.1007/s00774-021-01272-9. Epub 2021 Nov 3.

Association of Polypharmacy with Kidney Disease Progression in Adults with CKD.

Clin J Am Soc Nephrol. 2021 Dec;16(12):1797-1804. doi: 10.2215/CJN.03940321. Epub 2021 Nov 15.

Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.

Ther Adv Cardiovasc Dis. 2016 Aug;10(4):242-50. doi: 10.1177/1753944716634579. Epub 2016 Feb 25.

Prevalence of Impaired Kidney Function in the German Elderly: Results from the Berlin Aging Study II (BASE-II).

Gerontology. 2017;63(3):201-209. doi: 10.1159/000454831. Epub 2017 Feb 24.

Evaluation of polypharmacy among chronic kidney disease patients in Egypt: A cross-sectional study.

Int J Clin Pharmacol Ther. 2022 Sep;60(9):392-401. doi: 10.5414/CP204249.

本文引用的文献

Association of polypharmacy with incidence of CKD: a retrospective cohort study.

Clin Exp Nephrol. 2023 Mar;27(3):272-278. doi: 10.1007/s10157-022-02306-w. Epub 2022 Dec 27.

Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis.

Ther Adv Drug Saf. 2022 Aug 23;13:20420986221080795. doi: 10.1177/20420986221080795. eCollection 2022.

Polypharmacy and mortality association by chronic kidney disease status: The REasons for Geographic And Racial Differences in Stroke Study.

Pharmacol Res Perspect. 2021 Aug;9(4):e00823. doi: 10.1002/prp2.823.

Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease.

Kidney Blood Press Res. 2021;46(4):460-468. doi: 10.1159/000516029. Epub 2021 Jun 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Association of polypharmacy with incidence of CKD: a retrospective cohort study: a letter to the Editor.

作者信息

Danjuma M I, Alkaabi L, Sayed R, Naseralallah L

机构信息

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Department of Internal Medicine, Weill Cornell College of Medicine, New York and Doha, Qatar.

出版信息

Clin Exp Nephrol. 2024 May;28(5):470-471. doi: 10.1007/s10157-023-02443-w. Epub 2023 Dec 19.

DOI:10.1007/s10157-023-02443-w

PMID:38112981

Abstract

摘要

相似文献

Association of polypharmacy with incidence of CKD: a retrospective cohort study: a letter to the Editor.

Clin Exp Nephrol. 2024 May;28(5):470-471. doi: 10.1007/s10157-023-02443-w. Epub 2023 Dec 19.

Association of polypharmacy with incidence of CKD: a retrospective cohort study.

Clin Exp Nephrol. 2023 Mar;27(3):272-278. doi: 10.1007/s10157-022-02306-w. Epub 2022 Dec 27.

Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.

J Manag Care Spec Pharm. 2021 Jan;27(1):51-63. doi: 10.18553/jmcp.2021.27.1.051.

Association between polypharmacy and chronic kidney disease among community-dwelling older people: a longitudinal study in southern China.

BMC Nephrol. 2024 May 17;25(1):169. doi: 10.1186/s12882-024-03606-x.

Effect modification of polypharmacy on incident frailty by chronic kidney disease in older adults.

BMC Geriatr. 2024 Apr 12;24(1):335. doi: 10.1186/s12877-024-04887-5.

Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study.

J Bone Miner Metab. 2022 Jan;40(1):157-166. doi: 10.1007/s00774-021-01272-9. Epub 2021 Nov 3.

Association of Polypharmacy with Kidney Disease Progression in Adults with CKD.

Clin J Am Soc Nephrol. 2021 Dec;16(12):1797-1804. doi: 10.2215/CJN.03940321. Epub 2021 Nov 15.

Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.

Ther Adv Cardiovasc Dis. 2016 Aug;10(4):242-50. doi: 10.1177/1753944716634579. Epub 2016 Feb 25.

Prevalence of Impaired Kidney Function in the German Elderly: Results from the Berlin Aging Study II (BASE-II).

Gerontology. 2017;63(3):201-209. doi: 10.1159/000454831. Epub 2017 Feb 24.

Evaluation of polypharmacy among chronic kidney disease patients in Egypt: A cross-sectional study.

Int J Clin Pharmacol Ther. 2022 Sep;60(9):392-401. doi: 10.5414/CP204249.

本文引用的文献

Association of polypharmacy with incidence of CKD: a retrospective cohort study.

Clin Exp Nephrol. 2023 Mar;27(3):272-278. doi: 10.1007/s10157-022-02306-w. Epub 2022 Dec 27.

Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis.

Ther Adv Drug Saf. 2022 Aug 23;13:20420986221080795. doi: 10.1177/20420986221080795. eCollection 2022.

Polypharmacy and mortality association by chronic kidney disease status: The REasons for Geographic And Racial Differences in Stroke Study.

Pharmacol Res Perspect. 2021 Aug;9(4):e00823. doi: 10.1002/prp2.823.

Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease.

Kidney Blood Press Res. 2021;46(4):460-468. doi: 10.1159/000516029. Epub 2021 Jun 4.